Prone during pandemic: development and implementation of a quality-based protocol for proning severe COVID-19 hypoxic

Alfredo J Astua1, Eli K Michaels2, Andrew J Michaels3

  • 1Division of Pulmonary and Critical Care Medicine, NYCHHC/Elmhurst Hospital Center, New York City, USA.

BMC Pulmonary Medicine
|January 13, 2021
PubMed

Insights

Intermittent Prone Positioning (IPP) for Acute Respiratory Distress Syndrome (ARDS) improved oxygenation in COVID-19 patients. This safe and effective program can be implemented even in resource-limited settings.

Area of Science:

  • Critical Care Medicine
  • Pulmonary Medicine
  • Infectious Diseases

Background:

  • Intermittent Prone Positioning (IPP) is a proven method to decrease mortality in patients with Acute Respiratory Distress Syndrome (ARDS).
  • The COVID-19 pandemic has led to overwhelmed intensive care units (ICUs), particularly in low- and middle-income countries (LMICs), necessitating innovative treatment strategies.
  • This study presents an adaptable IPP program designed for resource-limited settings.

Purpose of the Study:

  • To describe the development and implementation of an Intermittent Prone Positioning (IPP) program for COVID-19 patients with ARDS.
  • To evaluate the effectiveness of this IPP program in improving oxygenation using readily available materials.
  • To demonstrate the program's applicability in settings with significant resource limitations.

Main Methods:

  • The IPP program was developed using principles from High Reliability Organizations (HROs) and Crew Resource Management (CRM).
  • Patients with severe ARDS (PaO2:FiO2 ratio [PFr] ≤ 150) received 16 hours of daily IPP.
  • Oxygenation (PFr, SaO2:FiO2 ratio [SaFr]) and ventilation (PaCO2) were measured at various time points; statistical analysis included t-statistics and ANOVA.

Main Results:

  • A total of 202 IPPs were performed on 29 patients during a peak mortality period.
  • Significant improvements in PFr (107.5 to 155.7, p<0.001) and SaFr (121.3 to 131.5, p=0.03) were observed within 1 hour of IPP.
  • Post-IPP supine SaFr further improved (139.7, p<0.001), while PaCO2 levels remained stable.

Conclusions:

  • An IPP program can be rapidly, safely, and effectively implemented for COVID-19 ARDS patients, even during mass casualty events.
  • This adaptable IPP approach is suitable for both LMICs and well-resourced centers facing temporary limitations.
  • The program's success highlights the potential of HRO and CRM principles in managing critical care scenarios with limited resources.
Abstract

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
434
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
756
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
298
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
569
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.4K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
518